These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22821386)

  • 1. Antipsychotics: a real or confounding risk factor for venous thromboembolism?
    Chapelle C; Quenet S; Delavenne X; Lacut K; Mismetti P; Laporte S; Beyens MN
    Pharmacopsychiatry; 2013 Jan; 46(1):36-7. PubMed ID: 22821386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotics and venous thromboembolism risk: a meta-analysis.
    Zhang R; Dong L; Shao F; Tan X; Ying K
    Pharmacopsychiatry; 2011 Jul; 44(5):183-8. PubMed ID: 21739416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic drugs and venous thromboembolism.
    Tromeur C; Couturaud F
    Thromb Res; 2012 Oct; 130 Suppl 1():S29-31. PubMed ID: 23026655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
    Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E
    Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.
    Schmedt N; Garbe E
    J Clin Psychopharmacol; 2013 Dec; 33(6):753-8. PubMed ID: 24052055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism during treatment with antipsychotic agents.
    Masopust J; Malý R; Vališ M
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):541-52. PubMed ID: 23252920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.
    Ishiguro C; Wang X; Li L; Jick S
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study.
    Wu CS; Lin CC; Chang CM; Wu KY; Liang HY; Huang YW; Tsai HJ
    J Clin Psychiatry; 2013 Sep; 74(9):918-24. PubMed ID: 24107765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients.
    Kleijer BC; Heerdink ER; Egberts TC; Jansen PA; van Marum RJ
    J Clin Psychopharmacol; 2010 Oct; 30(5):526-30. PubMed ID: 20814323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study.
    Wang MT; Liou JT; Huang YW; Lin CW; Wu GJ; Chu CL; Yeh CB; Wang YH
    Thromb Haemost; 2016 Jun; 115(6):1209-19. PubMed ID: 26941052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics and venous thrombosis. Confounding factors may account for the association.
    Curtis D
    BMJ; 2010 Oct; 341():c5628. PubMed ID: 20943734
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotics and the risk of venous thromboembolism.
    Liperoti R; Gambassi G
    BMJ; 2010 Sep; 341():c4216. PubMed ID: 20858908
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of venous thromboembolism due to antipsychotic drug therapy.
    Hägg S; Jönsson AK; Spigset O
    Expert Opin Drug Saf; 2009 Sep; 8(5):537-47. PubMed ID: 19569978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis.
    Arasteh O; Nomani H; Baharara H; Sadjadi SA; Mohammadpour AH; Ghavami V; Sathyapalan T; Sahebkar A
    Curr Vasc Pharmacol; 2020; 18(6):632-643. PubMed ID: 32066363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotics and venous thrombosis. Dutch experience differs.
    Kleijer BC; Heerdink ER; van Marum RJ
    BMJ; 2010 Oct; 341():c5631. PubMed ID: 20943736
    [No Abstract]   [Full Text] [Related]  

  • 16. Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.
    Jönsson AK; Schill J; Olsson H; Spigset O; Hägg S
    CNS Drugs; 2018 Jan; 32(1):47-64. PubMed ID: 29423659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
    Ageno W; Becattini C; Brighton T; Selby R; Kamphuisen PW
    Circulation; 2008 Jan; 117(1):93-102. PubMed ID: 18086925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association and Influencing Factors between Antipsychotics Exposure and the Risk of VTE and PE: A Systematic Review and Meta-analysis.
    Dai L; Zuo Q; Chen F; Chen L; Shen Y
    Curr Drug Targets; 2020; 21(9):930-942. PubMed ID: 32321400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Rate of Antipsychotic Use in Ambulatory Care Patients With a Venous Thromboembolism.
    Rarrick C; Saccone N; Hebbard A; Jones B
    Ann Pharmacother; 2020 Feb; 54(2):97-104. PubMed ID: 31416330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.